Trabectedin for Recurrent Grade II/III Meningioma
Clinical trial NCT02234050 · COMPLETED
Trial details
- NCT number
- NCT02234050
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2017-07-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.